TR201916829A2 - Dapagli̇flozi̇n ve metformi̇n i̇çeren çi̇ft katmanli tablet formülasyonlari - Google Patents
Dapagli̇flozi̇n ve metformi̇n i̇çeren çi̇ft katmanli tablet formülasyonlari Download PDFInfo
- Publication number
- TR201916829A2 TR201916829A2 TR2019/16829A TR201916829A TR201916829A2 TR 201916829 A2 TR201916829 A2 TR 201916829A2 TR 2019/16829 A TR2019/16829 A TR 2019/16829A TR 201916829 A TR201916829 A TR 201916829A TR 201916829 A2 TR201916829 A2 TR 201916829A2
- Authority
- TR
- Turkey
- Prior art keywords
- metformin
- dapaglyflozin
- dual
- tablet formulations
- formulations containing
- Prior art date
Links
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 title abstract 3
- 229960003105 metformin Drugs 0.000 title abstract 3
- 239000007916 tablet composition Substances 0.000 title abstract 2
- 239000002355 dual-layer Substances 0.000 title 1
- JVHXJTBJCFBINQ-ADAARDCZSA-N Dapagliflozin Chemical compound C1=CC(OCC)=CC=C1CC1=CC([C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=CC=C1Cl JVHXJTBJCFBINQ-ADAARDCZSA-N 0.000 abstract 2
- 229960003834 dapagliflozin Drugs 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Buluş, dapagliflozin veya dapagliflozinin farmasötik olarak kabul edilebilir bir tuzu ve metformin ve metforminin farmasötik olarak kabul edilebilir bir tuzu ile gerçekleştirilen çift katmanlı tablet formülasyonlar ile ilgilidir.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2019/16829A TR201916829A2 (tr) | 2019-10-31 | 2019-10-31 | Dapagli̇flozi̇n ve metformi̇n i̇çeren çi̇ft katmanli tablet formülasyonlari |
PCT/TR2020/050996 WO2021086292A1 (en) | 2019-10-31 | 2020-10-27 | Bilayer tablet formulations comprising dapagliflozin and metformin |
EP20881133.1A EP4051246A4 (en) | 2019-10-31 | 2020-10-27 | DUAL-LAYER EFFORTABLE TABLET FORMULATIONS WITH DAPAGLIFLOZIN AND METFORMIN |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2019/16829A TR201916829A2 (tr) | 2019-10-31 | 2019-10-31 | Dapagli̇flozi̇n ve metformi̇n i̇çeren çi̇ft katmanli tablet formülasyonlari |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201916829A2 true TR201916829A2 (tr) | 2021-05-21 |
Family
ID=75716198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2019/16829A TR201916829A2 (tr) | 2019-10-31 | 2019-10-31 | Dapagli̇flozi̇n ve metformi̇n i̇çeren çi̇ft katmanli tablet formülasyonlari |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP4051246A4 (tr) |
TR (1) | TR201916829A2 (tr) |
WO (1) | WO2021086292A1 (tr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR202019592A2 (tr) * | 2020-12-03 | 2022-06-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Amorf dapagliflozinin katı farmasötik formülasyonları |
TR202019590A2 (tr) * | 2020-12-03 | 2022-06-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Dapagli̇flozi̇n ve metformi̇n hi̇droklorür formülasyonlarina yöneli̇k bi̇r proses |
WO2022119543A1 (en) * | 2020-12-03 | 2022-06-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | A process for tablet formulations comprising amorphous dapagliflozin and metformin hydrochloride |
EP4212150A1 (en) * | 2022-01-13 | 2023-07-19 | Sanovel Ilac Sanayi Ve Ticaret A.S. | A bilayer tablet composition comprising amorphous dapagliflozin and metformin |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010045656A2 (en) | 2008-10-17 | 2010-04-22 | Nectid, Inc. | Novel sglt2 inhibitor dosage forms |
CA2780939C (en) * | 2009-11-13 | 2018-06-12 | Bristol-Myers Squibb Company | Bilayer tablet formulations |
RU2012155890A (ru) * | 2010-06-22 | 2014-07-27 | ТиДаблЮАй ФАРМАСЬЮТИКАЛЗ, ИНК. | Композиции с контролируемым высвобождением с пониженным воздействием пищи |
-
2019
- 2019-10-31 TR TR2019/16829A patent/TR201916829A2/tr unknown
-
2020
- 2020-10-27 EP EP20881133.1A patent/EP4051246A4/en active Pending
- 2020-10-27 WO PCT/TR2020/050996 patent/WO2021086292A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP4051246A1 (en) | 2022-09-07 |
WO2021086292A1 (en) | 2021-05-06 |
EP4051246A4 (en) | 2023-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR201916829A2 (tr) | Dapagli̇flozi̇n ve metformi̇n i̇çeren çi̇ft katmanli tablet formülasyonlari | |
DOP2020000102A (es) | Compuestos útiles para inhibir a cdk7 | |
DOP2017000306A (es) | Formulaciones farmacéuticas que contienen tenofovir y emtricitabina | |
PH12018500047B1 (en) | Notch pathway signaling inhibitor compounds | |
CY1110097T1 (el) | Διπλοστοιβαδικο δισκιο για προληψη καρδιαγγειακων συμβαντων | |
BR112017028140A2 (pt) | formulações farmacêuticas | |
EA202191806A1 (ru) | Антитело против человеческого il-4ra и его применение | |
EA201690679A1 (ru) | Стабильная фармацевтическая композиция, содержащая амлодипин и валсартан | |
MX2020005483A (es) | Antagonistas de ildr2 y combinaciones de los mismos. | |
CO2021017317A2 (es) | Células seguras e invisibles para el sistema inmunitario | |
EA202090542A1 (ru) | Высококонцентрированные лекарственные формы придопидина | |
CL2020002199A1 (es) | Compuesto de anillo de metillactama y uso farmacéutico del mismo. | |
TR201914043A1 (tr) | Dapagli̇flozi̇n ve metformi̇n i̇çeren efervesan tablet formülasyonlari | |
EA202090270A1 (ru) | Новые замещенные производные ксантина | |
TR201913472A2 (tr) | Vi̇ldagli̇pti̇n ve metformi̇n i̇çeren bi̇r kombi̇nasyon | |
TR201713954A2 (tr) | Tenofovir, emtrisitabin ve efavirenzin farmasötik kombinasyonlari | |
CY1120192T1 (el) | Ενωσεις για την ενισχυση της γνωστικης λειτουργιας | |
BR112022012584A2 (pt) | Compostos e derivados de hidroxiestilbeno substituído, síntese e uso deles | |
EA201890929A1 (ru) | Низкие дозировки композиций дипиридамола для перорального приема и их использование | |
CY1123076T1 (el) | Ενωσεις βενζο-ν-υδροξυ αμιδιου που εχουν αντικαρκινικη δραστikothta | |
CL2020000120A1 (es) | Composiciones farmacéuticas. | |
CL2019000572A1 (es) | Compuesto de imida y uso del mismo. | |
EA202091403A1 (ru) | Производные 2-оксо-1-пирролидинилимидазотиадиазола | |
TR201721824A2 (tr) | Li̇nagli̇pti̇n ve metformi̇n i̇çeren modi̇fi̇ye salim sağlayan kombi̇nasyon | |
TR201914420A2 (tr) | Sapropteri̇n di̇hi̇droklorür ve en az bi̇r anti̇oksi̇dan i̇çeren farmasöti̇k formülasyonlar |